Amber Pharmacy Announces Strategic Leadership Changes

OMAHA, Nebraska (April 25, 2019) — Today, Amber Pharmacy, a subsidiary of Hy-Vee, Inc. announced that Aaron Wiese has been named president of Amber Pharmacy and Hy-Vee Pharmacy Solutions. Mike Agostino, president of Amber Pharmacy since 2017, has been named senior vice president of pharmacy business development at Hy-Vee’s corporate office.

“As the health care landscape continues to evolve, we need someone who can help us focus on expanding our services to our patients,” said Randy Edeker, chairman, CEO and president, Hy-Vee. “Mike is the perfect person to work on new strategies and develop both specialty and traditional pharmacy opportunities so we can provide expanded patient services.”

Agostino holds a Bachelor of Science degree in pharmacy from Northeastern University, and is the past president of the National Association of Specialty Pharmacy. He currently serves on the board of the association, and is a member of the Executive Committee, Membership Committee and Government Affairs Committee. Agostino has been with Amber Pharmacy since 2008.

With Agostino’s move, Aaron Wiese has been named president of Amber Pharmacy and Hy-Vee Pharmacy Solutions. Wiese has been an integral part of leading Hy-Vee’s health and wellness efforts since 2013, and brings a great deal of experience to his role as president.

“Aaron has amassed a great amount of knowledge in all aspects of health, wellness and pharmacy,” Edeker said. “The specialty pharmacy business is very challenging, but is a key part of our overall health strategy and making sure we’re taking the best care possible of our patients. Aaron is the right leader for these areas as we position ourselves for future growth.”

Wiese has been with Hy-Vee since 1993. He has served in multiple areas of Hy-Vee’s health and wellness operations, most recently as vice president, Hy-Vee HealthMarkets/health & wellness strategy. He also has served in several leadership positions at Amber Pharmacy prior to that.

Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 

Related Articles

Midazolam (Nayzilam) is indicated for seizures that are distinct from a patient's usual seizure pattern, in individuals age 12 years and older with epilepsy.
Matthew Malachowski, PharmD, BCPS, supervisor of specialty pharmacy services at UAB Health System, discusses how to optimize collaboration among the health care team to prepare for changes that occur throughout the course of a patient's care.
The convenience of home infusion for these products is very enticing for patients who require them and positioning home infusion pharmacies as partners with prescribers and patients is critical to help support this influx of new therapies.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.